SCHEMBL15545879

SCHEMBL15545879

O=C(C1CNc2cc([N+](=O)[O-])ccc21)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
MAPT P10636 4/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 5/20 0.43
MEN1 O00255 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
P2RX4 Q99571 1/20 0.42
P2RX7 Q99572 1/20 0.42
P2RX2 Q9UBL9 1/20 0.42
CHRNB4 P30926 4/20 0.41
CHRNA3 P32297 4/20 0.41
POLB P06746 1/20 0.40
CHRNB2 P17787 2/20 0.39
CHRNA4 P43681 2/20 0.39
NPSR1 Q6W5P4 2/20 0.37
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15544368 0.91 ALDH1A1 (0.44) ALDH1A1MAPTL3MBTL1KMT2AMEN1
SCHEMBL15544668 0.81 ALDH1A1 (0.43) ALDH1A1MAPTKMT2AMEN1LMNA
SCHEMBL15545277 0.77 SMN1; SMN2 (0.47) MAPTKMT2AMEN1SMN1; SMN2KDM4E
SCHEMBL15545467 0.77 KCNH2 (0.41) ALDH1A1MAPTKDM4EP2RX7RAB9A
SCHEMBL15545602 0.75 ALDH1A1 (0.35) ALDH1A1LMNAHTTSMN1; SMN2P2RX7
SCHEMBL15544852 0.74 LMNA (0.43) ALDH1A1KMT2AMEN1LMNASMN1; SMN2
SCHEMBL15544370 0.73 CNR2 (0.41) ALDH1A1LMNAHTTSMN1; SMN2P2RX7
SCHEMBL15545052 0.73 P2RX4 (0.39) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL5803808 0.71 TSHR (0.42) ALDH1A1KMT2AMEN1CHRNB4CHRNA3
SCHEMBL27492634 0.69 CHRNB4 (0.49) ALDH1A1MAPTL3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2870139-A1 NOVEL ADAMANTYL DERIVATIVES AS CANNABINOID RECEPTOR 2 AGONISTS F. Hoffmann-La Roche AG (CH) 2015-05-13 EP disclosed
WO-2014005968-A1 NOVEL ADAMANTYL DERIVATIVES AS CANNABINOID RECEPTOR 2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2014-01-09 WO disclosed